MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization

Severin Guetter(University Hospital Regensburg), Melanie Werner‐Klein(University Hospital Regensburg), Mark Berneburg(University Hospital Regensburg), Christian M. Schürch(University Children's Hospital Tübingen), Huiqin Koerkel-Qu(University of Regensburg), Philipp Renner(Robert Bosch Hospital), Sebastian Haferkamp(University Hospital Regensburg), Christian Werno(Fraunhofer Institute for Toxicology and Experimental Medicine), Parvaneh Mohammadi(University of Regensburg), Courtney König(University of Regensburg), Lisa Schmidleithner(University Hospital Regensburg), Kathrin Weidele(Fraunhofer Institute for Toxicology and Experimental Medicine), Jens Warfsmann(Fraunhofer Institute for Toxicology and Experimental Medicine), Sebastian Scheitler(University of Regensburg), Alexander Rochwarger, Armin Braun(Medizinische Hochschule Hannover), Katharina Limm(University of Regensburg), Veronika Naimer(University of Regensburg), Florian Weber(University of Augsburg), Christoph A. Klein(University Hospital Regensburg), Beatrix Cucuruz(University Hospital Regensburg), Reinhard Rachel(University of Regensburg), Peter J. Oefner, Felix Baumann(University of Regensburg), Steffi Treitschke(Fraunhofer Institute for Toxicology and Experimental Medicine), Anja Ulmer(University of Tübingen), Katja Evert(University Hospital Regensburg), Leonhard Guttenberger(University of Regensburg), Hanna Jaser(University of Regensburg), Marie Katzer(University Hospital Regensburg), Tonia Bargmann(Fraunhofer Institute for Toxicology and Experimental Medicine), Kathrin Guetter(University Hospital Regensburg), Aleksandra Markiewicz(University of Regensburg)
Nature Cancer
May 16, 2025
Cited by 12


Related Papers